3 key challenges discussed at Cell & Gene Meeting on the Mesa

Published on October 26, 2023

At the 2023 Cell & Gene Meeting on the Mesa earlier this month, senior executives and top decision-makers discussed commercialization challenges facing the cell and gene therapy sector. This year’s conference called out some of the biggest issues that the industry is facing. Leaders discussed challenges ranging from manufacturing scalability issues to gaps in Medicare […]

Continue reading on website
Other news

6 Step guide: Successfully navigating complexities of drug development

October 25, 2023
Not only is developing a new drug expensive, but an extraordinarily lengthy and complex process. In fact, some estimate that drug development can cost upwards of $2.8 billion and take 10-15 years. From the initial stages of drug discovery, clinical trials and regulatory approvals, to pre-and post-launch strategizing and commercialization, pharmaceutical companies face numerous obstacles […]

Webinar: Evolution of Immunogenicity Assessment

October 27, 2023
Join Abzena’s Director of Immunology, Edward Cloake and Sr. Manager of Immunology, Beverley Campbell on November 1st for a live webinar entitled: Evolution of Immunogenicity AssessmentClick Here to RegisterPresentation OverviewConducting immunogenicity risk assessment as part of a developability package and lead candidate selection before clinical trials de-risks the development of biologics and s